Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma.

Chapman, Kenneth R; Watz, Henrik; Singh, Dave; Hohlfeld, Jens M; Diamant, Zuzana; Jones, Ieuan; Tillmann, Hanns-Christian; Nikolaev, Ivan

Chapman, Kenneth R; Watz, Henrik; Singh, Dave; Hohlfeld, Jens M; Diamant, Zuzana; Jones, Ieuan; Tillmann, Hanns-Christian; Nikolaev, Ivan.

Afiliación

Chapman KR; Division of Respiratory Medicine, Department of Medicine, University of Toronto, Toronto, Canada.
Watz H; Asthma & Airway Centre, University Health Network, Toronto, Canada.
Singh D; Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany.
Hohlfeld JM; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK.
Diamant Z; Fraunhofer Institute of Toxicology and Experimental Medicine and Respiratory Medicine of Hannover Medical School, Member of the German Center for Lung Research (DZL), Hannover, Germany.
Jones I; Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
Tillmann HC; Department of Microbiology Immunology and Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.
Nikolaev I; Department of Clinical Pharmacy and Pharmacology, UMCG and QPS Netherlands, Groningen, The Netherlands.

Clin Drug Investig ; 41(5): 489-492, 2021 05.

Article en En | MEDLINE | ID: mdl-33864631

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Clin Drug Investig Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google